GSGCX
Price
$47.55
Change
+$0.48 (+1.02%)
Updated
Dec 3 closing price
Net Assets
422.66M
VIVAX
Price
$74.34
Change
+$0.66 (+0.90%)
Updated
Dec 3 closing price
Net Assets
207.95B
Interact to see
Advertisement

GSGCX vs VIVAX

Header iconGSGCX vs VIVAX Comparison
Open Charts GSGCX vs VIVAXBanner chart's image
Goldman Sachs Equity Income C
Price$47.55
Change+$0.48 (+1.02%)
VolumeN/A
Net Assets422.66M
Vanguard Value Index I
Price$74.34
Change+$0.66 (+0.90%)
VolumeN/A
Net Assets207.95B
GSGCX vs VIVAX Comparison Chart in %
View a ticker or compare two or three
VS
GSGCX vs. VIVAX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSGCX is a Hold and VIVAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 208B vs. GSGCX (423M). VIVAX pays higher dividends than GSGCX: VIVAX (1.93) vs GSGCX (0.57). GSGCX was incepted earlier than VIVAX: GSGCX (28 years) vs VIVAX (33 years). GSGCX (1.95) is less costly to investors than VIVAX (0.17). GSGCX is a more actively managed with annual turnover of: 31.00 vs. VIVAX (9.00). GSGCX has a lower initial minimum investment than VIVAX: GSGCX (1000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 4.76 vs. GSGCX (-3.32). VIVAX return over 5 years is better than : 61.14 vs. GSGCX (28.21).
GSGCXVIVAXGSGCX / VIVAX
Total Expense Ratio1.750.171,029%
Annual Report Gross Expense Ratio1.950.171,147%
Fund Existence28 years33 years-
Gain YTD10.90211.75393%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets423M208B0%
Annual Yield % from dividends0.571.9330%
Returns for 1 year-3.324.76-70%
Returns for 3 years13.1329.7944%
Returns for 5 years28.2161.1446%
Returns for 10 years68.26127.2154%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EGHAU10.55N/A
N/A
EGH Acquisition Corp.
ZH3.50-0.01
-0.28%
Zhihu
GRCE3.14-0.03
-0.89%
Grace Therapeutics Inc
BRX25.53-0.36
-1.39%
Brixmor Property Group
UPB25.01-3.97
-13.70%
Upstream Bio Inc